Abstract
Biotechnology Law ReportVol. 39, No. 3 As presented by Chris HolmanValeant Pharm. Int'l, Inc. v. Mylan Pharm. Inc. United States Court of Appeals of the Federal Circuit, 2020 955 F.3d 25Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*Published Online:3 Jun 2020https://doi.org/10.1089/blr.2020.29175.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 39Issue 3Jun 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Valeant Pharm. Int'l, Inc. v. Mylan Pharm. Inc. United States Court of Appeals of the Federal Circuit, 2020 955 F.3d 25.Biotechnology Law Report.Jun 2020.256-261.http://doi.org/10.1089/blr.2020.29175.cmhPublished in Volume: 39 Issue 3: June 3, 2020PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
